Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
OSE Immunotherapeutics SA
F:6OP
OSE Immunotherapeutics SA
F:6OP
Price:
1.993
EUR
-2.88%
Market Cap:
€43.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
OSE Immunotherapeutics SA
F:6OP
|
FR |
|
P
|
Pool Corp
F:SP1
|
US |
|
C
|
China Energy Engineering Corp Ltd
F:2E5
|
CN |
|
Belluna Co Ltd
F:73L
|
JP |
|
S
|
Soosan Heavy Industries Co Ltd
KRX:017550
|
KR |
|
P
|
Pensana PLC
F:48W
|
UK |
|
F
|
First Solar Inc
DUS:F3A
|
US |
|
Flameret Inc
OTC:FLRE
|
US |
Wall St Price Targets
6OP Price Forecast
Based on 6 analysts
Based on 6 analysts
+366% Upside
from
€1.993
today
OSE Immunotherapeutics SA (6OP)’s 12-month stock price forecast through October 2027 has a consensus target of €9.284, implying 366% upside. The forecast is based on price targets from 6 Wall Street analysts.
6OP Analyst Rating
No ratings yet
No ratings yet
OSE Immunotherapeutics SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6OP's stock price target?
Price Target
9.284
EUR
9.284
EUR
According to Wall Street analysts, the average 1-year price target for 6OP is 9.284 EUR with a low forecast of 7.771 EUR and a high forecast of 20.69 EUR.
What is the Revenue forecast for OSE Immunotherapeutics SA?
Projected CAGR
234%
234%
The compound annual growth rate for Revenue over the next 3 years is 234%.